Role of isoflavones in multiple sclerosis

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Multiple sclerosis (MS) involves myelin degeneration and Central Nervous System (CNS) communication disruption.
• Oxidative stress and inflammation are key factors in MS pathophysiology.
• Isoflavones, a class of phytoestrogens from soy, exhibit potential anti-inflammatory and neuroprotective effects.

Purpose of the Study:

• To review the current literature on the role of isoflavones in multiple sclerosis.
• To examine the mechanisms of action of isoflavones in the context of MS.
• To assess the preclinical evidence supporting isoflavones as a therapeutic strategy for MS.

Main Methods:

• Comprehensive literature review from 2000-2024.
• Searched databases including PubMed, Scopus, ScienceDirect, and Google Scholar.
• Used search terms like "isoflavones" AND "multiple sclerosis" and "phytoestrogens" AND "neuroprotection".

Main Results:

• Preclinical data suggests isoflavones can modulate immune responses and exert antioxidant effects.
• Evidence indicates isoflavones may reduce inflammation and slow neurodegeneration in MS models.
• Potential for isoflavones to aid in myelin repair and disease progression management.

Conclusions:

• Isoflavones demonstrate promising therapeutic potential for multiple sclerosis.
• Further research is required to validate their efficacy and safety as supplemental MS therapies.
• Clinical trials are necessary to translate preclinical findings into practical treatment strategies.